Amedisys (NASDAQ:AMED) Sets New 1-Year Low – What’s Next?

Amedisys, Inc. (NASDAQ:AMED) shares hit a new 52-week low during trading on Thursday . The stock traded as low as $83.73 and last traded at $83.78, with a volume of 910801 shares traded. The stock had previously closed at $84.97.

Amedisys Trading Up 0.8 %

The stock has a market capitalization of $2.77 billion, a P/E ratio of 33.52, a P/E/G ratio of 1.84 and a beta of 0.73. The company has a current ratio of 1.19, a quick ratio of 1.19 and a debt-to-equity ratio of 0.05. The business has a 50-day moving average price of $91.75 and a two-hundred day moving average price of $94.68.

Amedisys (NASDAQ:AMED) last issued its earnings results on Wednesday, November 6th. The health services provider reported $1.00 EPS for the quarter, missing the consensus estimate of $1.19 by ($0.19). Amedisys had a net margin of 3.57% and a return on equity of 12.20%. The firm had revenue of $587.67 million during the quarter, compared to analyst estimates of $586.75 million. During the same quarter in the previous year, the firm posted $0.98 earnings per share. Amedisys’s quarterly revenue was up 5.7% compared to the same quarter last year. On average, analysts expect that Amedisys, Inc. will post 4.45 EPS for the current fiscal year.

Institutional Trading of Amedisys

Hedge funds and other institutional investors have recently modified their holdings of the stock. KBC Group NV bought a new position in Amedisys in the 3rd quarter valued at approximately $63,000. Innealta Capital LLC bought a new position in shares of Amedisys during the second quarter valued at $64,000. Signaturefd LLC lifted its holdings in shares of Amedisys by 88.2% during the second quarter. Signaturefd LLC now owns 1,131 shares of the health services provider’s stock worth $104,000 after purchasing an additional 530 shares during the period. CWM LLC grew its stake in shares of Amedisys by 14.5% in the third quarter. CWM LLC now owns 2,190 shares of the health services provider’s stock worth $211,000 after purchasing an additional 277 shares during the last quarter. Finally, Crossmark Global Holdings Inc. bought a new position in Amedisys during the 3rd quarter worth $243,000. Institutional investors own 94.36% of the company’s stock.

Amedisys Company Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.